Oncology
Overview
Oncology is a peer-reviewed journal that focuses on the latest advancements in cancer research and treatment. It covers a wide range of topics including molecular biology, immunotherapy, clinical trials, and personalized medicine. With contributions from leading experts in the field, Oncology provides valuable insights and updates for oncologists, researchers, and healthcare professionals striving to improve patient outcomes in the fight against cancer.
Details
Details
Abbr.
Oncology
Start
1967
End
Continuing
Frequency
Eight no. a year, 2007-
p-ISSN
0030-2414
e-ISSN
1423-0232
Country
Switzerland
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 2769
107
SJR / Ranks: 4982
832
CiteScore / Ranks: 3827
6.00
JIF / Ranks: 2766
3.5
Recent Articles
1.
Kim K, Moon W, Ha G, Park H, Jang K, Lee M, et al.
Oncology
. 2025 Mar;
:1-17.
PMID: 40081338
Introduction: In colorectal cancer (CRC), the prognostic significance of Adenomatous polyposis coli (APC) mutations remains controversial. We aimed to investigate the effect of APC mutations on the prognosis of patients...
2.
Guijosa A, Cabrera-Miranda L, Gomez-Garcia A, Trejo Rosales R, Munoz-Montano W, Flores D, et al.
Oncology
. 2025 Mar;
:1-16.
PMID: 40068665
Introduction: Pleural Mesothelioma (PM) is a rare and aggressive cancer where prognostic assessment is crucial. Traditional prognostic scores such as the European Organisation for Research and Treatment of Cancer (EORTC)...
3.
Zhang J, Toyozum T, Kano M, Matsumoto Y, Otsuka R, Sekino N, et al.
Oncology
. 2025 Mar;
:1-17.
PMID: 40068649
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most malignant cancers in the world, which seriously affects the survival and quality of life of patients. Aberrant expression of...
4.
Dolci M, Civettini I, Bagnoli P, Toumi W, Signorini L, Crocchiolo R, et al.
Oncology
. 2025 Mar;
:1-16.
PMID: 40068636
Introduction: Human Endogenous RetroViruses (HERVs) account for approximately 8% of the human genome, where they are integrated and typically remain silent. Despite their inactivation, numerous retroviral sequences retain intact open...
5.
Hashimoto K, Yokokawa T, Nonomiya Y, Shibata N, Soejima A, Kobayashi K, et al.
Oncology
. 2025 Mar;
:1-23.
PMID: 40064150
Introduction: Age has been reported as a risk factor for chemotherapy-induced nausea and vomiting. However, few reports have described risk factors for nausea and vomiting with carboplatin (CBDCA). This study...
6.
Dai X, Li H, Qiu H, Han Y, Qi X, Chen D, et al.
Oncology
. 2025 Mar;
:1-24.
PMID: 40064148
Introduction: The early lung adenocarcinoma detection rate has increased with the development and application of low-dose computed tomography. However, overdiagnosis and overtreatment are frequent. Here, we established a cytology grading...
7.
Lin Y, Chen J, Yan L, Deng M, Ding J
Oncology
. 2025 Mar;
:1-9.
PMID: 40024221
Introduction: The aim was to evaluate the prognostic values of pretreatment 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) parameters for predicting local failure in nasopharyngeal carcinoma (NPC) patients in the intensity-modulated...
8.
Yu X, Xu L, Zhang S, Pan P, Xia Y
Oncology
. 2025 Feb;
:1-22.
PMID: 40010326
Introduction: Research on esophageal squamous cell carcinoma (ESCC) in Asian American (AsA) populations frequently aggregates data, thereby overlooking the considerable diversity inherent within this demographic. The aim of this study...
9.
Schulenburg A, Rusing L, Bumberger A, Mitterbauer M, Cserna J, Petrasch C, et al.
Oncology
. 2025 Feb;
:1-4.
PMID: 39999826
Introduction: Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment for hematologic malignancies, offering significant therapeutic benefits. However, this therapy is also associated with adverse effects such...
10.
Haisraely O, Jaffe M, Taliansky A, Cohen Z, Lawerence Y
Oncology
. 2025 Feb;
:1-16.
PMID: 39999822
Introduction: Central nervous system solitary fibrous tumors (cSFTs) are rare, accounting for less than 1% of CNS tumors. Treatment guidelines are limited, especially for frail or elderly patients. Gross total...